India's pharma and MedTech industries await the change with the launch of the Rs. 5,000-crore Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme.
Danish pharmaceutical leader Novo Nordisk is targeting $1 billion (Rs 8,600 crore) in sales in India with its highly successful weight-loss medication Wegovy (semaglutide) within the next five to seven years. To achieve this goal, ET has learned that
Immuno Cure BioTech, located in Hong Kong Science Park, has formed a partnership with PharmaJet to assess the safety and immunogenicity of ICVAX, Immuno Cure's HIV therapeutic DNA
The Indian Council of Medical Research’s National Institute of Immunohaematology (ICMR-NIIH) has developed the world’s first simple...
The Indian pharma sector is experiencing a remarkable shift, growing from the cost-driven outsourcing model into a bustling center of innovation, research, and international alliances.
Amazon India expanded its healthcare services further with the launch of Amazon Diagnostics, an in-home diagnostic testing service to deliver quick, secure, and easy lab testing to the doorsteps of customers.
In an exclusive interaction with India Pharma Outlook, Dr. Pankaj Gupta, Senior Medical Director at Pfizer India, sheds light on the escalating threat of antimicrobial resistance in India’s ICUs. He discusses evo
On June 25, 2025, the Confederation of Indian Industry (CII), Telangana will hold a day-long conference, ‘Pillars of Protection – Forging a Safer Future for Pharma and Chemical Manufacturing’ in Hyderabad...
Building on the strong momentum of Mounjaro’s rollout in India, Eli Lilly has reported encouraging clinical trial results for its oral anti-obesity drug, Orforglipron. The new once-daily pill, part of the same GLP-1 drug class as Mounjaro and Zepboun
Following its prior report on the clinical success of Mounjaro, Eli Lilly has confirmed a considerable commercial response for the drug in India - the need for effective obesity and diabetes treatment is...
, CDSCO.jpg)
